Exact Imaging, the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, has introduced its new FusionVu micro-US/MRI fusion application to complement its ExactVu micro-ultrasound system for prostate imaging and biopsy.

“At least 70% of prostate cancer is located in the peripheral zone, which is exquisitely visualized and targetable with the 70 micron resolution of the ExactVu micro-ultrasound system,” says Randy AuCoin, Exact Imaging’s president and chief executive officer. “Our evidence-based PRI-MUS protocol is easily applied to help urologists identify and characterize regions and then to target those suspicious regions. For the minority of cases, such as patients with previous negative biopsies or those with exclusive anterior lesions, Exact Imaging is introducing its FusionVu micro-US/MRI fusion solution. The ExactVu micro-ultrasound platform with FusionVu is a total urological solution and is easily upgradable, scalable and provides a smart, practical investment pathway for urologists.

FusionVu uses an approach called Cognitive Assist whereby the urologist can quickly and easily import radiological reports from MRI scans or import the annotated MR images themselves. These images with MRI-identified lesions are co-aligned with the live ExactVu micro-ultrasound images. In this way, the urologist can identify and target lesions using PRI-MUS and ExactVu for the majority of cases but, when needed, can also leverage MRI-identified lesions to ensure they are not missed in the total biopsy procedure. The FusionVu application runs on the the ExactVu platform, does not require any new hardware or radiological software, and is completely focused on the standard urological workflow. It is easy to implement, easy to learn - - because its ultrasound-based - - and cost-effective to implement.

Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Exact Imaging’s ExactVu micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and being an extension of the current urological workflow. Using the Exact Imaging platform, urologists will now be able to visualize areas of interest in the prostate and specifically target biopsies at those areas in addition to performing systematic biopsy protocols. The ExactVu micro-ultrasound system has recently been granted regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)) and Canada (Health Canada license).